Paper40997223
Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus.
Rico V and 39 others. J Alzheimers Dis, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus. Papers, record 40997223. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40997223
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Information Dissemination | Major topic |
| Biomedical Research | Major topic |
| Humans | |
| Delphi Technique | |
| Surveys and Questionnaires |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K23 AG070044 | NIA NIH HHS | United States | K23AG070044 | PubMed | NIH RePORTER |
| P30 AG072959 | NIA NIH HHS | United States | P30AG072959 | PubMed | NIH RePORTER |
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26501506 | Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results. | JAMA Neurol | 2015 | https://conductscience.org/library/papers/26501506 | PubMed |
| 2 | 30830824 | Understanding What Information Is Valued By Research Participants, And Why. | Health Aff (Millwood) | 2019 | https://conductscience.org/library/papers/30830824 | PubMed |
| 3 | 34748551 | Return of individual research results from genomic research: A systematic review of stakeholder perspectives. | PLoS One | 2021 | https://conductscience.org/library/papers/34748551 | PubMed |
| 4 | 30522811 | A Preliminary Study of Clinical Trial Enrollment Decisions Among People With Mild Cognitive Impairment and Their Study Partners. | Am J Geriatr Psychiatry | 2019 | https://conductscience.org/library/papers/30522811 | PubMed |
| 5 | 26750717 | Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability. | Alzheimers Dement | 2016 | https://conductscience.org/library/papers/26750717 | PubMed |
| 6 | 22829486 | Beyond PICO: the SPIDER tool for qualitative evidence synthesis. | Qual Health Res | 2012 | https://conductscience.org/library/papers/22829486 | PubMed |
| 7 | 36180237 | Preclinical Alzheimer Disease and the Electronic Health Record: Balancing Confidentiality and Care. | Neurology | 2022 | https://conductscience.org/library/papers/36180237 | PubMed |
| 8 | 30094328 | Amyloid positron emission tomography candidates may focus more on benefits than risks of results disclosure. | Alzheimers Dement (Amst) | 2018 | https://conductscience.org/library/papers/30094328 | PubMed |
| 9 | 25969699 | Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants. | Alzheimers Res Ther | 2015 | https://conductscience.org/library/papers/25969699 | PubMed |
| 10 | 37890053 | Perspectives From Black and White Participants and Care Partners on Return of Amyloid and Tau PET Imaging and Other Research Results. | Alzheimer Dis Assoc Disord | 2023 | https://conductscience.org/library/papers/37890053 | PubMed |
| 11 | 35366050 | Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial. | Alzheimers Dement | 2023 | https://conductscience.org/library/papers/35366050 | PubMed |
| 12 | 36278354 | Disclosing Individual Results in Dementia Research: A Proposed Study Participant's Bill of Rights. | J Alzheimers Dis | 2022 | https://conductscience.org/library/papers/36278354 | PubMed |
| 13 | 28012682 | Disclosing genetic risk of Alzheimer's disease to cognitively impaired patients and visit companions: Findings from the REVEAL Study. | Patient Educ Couns | 2017 | https://conductscience.org/library/papers/28012682 | PubMed |
| 14 | 23649902 | Patient and carer views on participating in clinical trials for prodromal Alzheimer's disease and mild cognitive impairment. | Int J Geriatr Psychiatry | 2014 | https://conductscience.org/library/papers/23649902 | PubMed |
| 15 | 22213783 | Balancing the risks and benefits of genomic data sharing: genome research participants' perspectives. | Public Health Genomics | 2012 | https://conductscience.org/library/papers/22213783 | PubMed |
| 16 | 29197423 | Amnestic MCI patients' experiences after disclosure of their amyloid PET result in a research context. | Alzheimers Res Ther | 2017 | https://conductscience.org/library/papers/29197423 | PubMed |
| 17 | 36720642 | Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease Continuum. | Neurology | 2023 | https://conductscience.org/library/papers/36720642 | PubMed |
| 18 | 30147000 | The Proactive Patient: Long-Term Care Insurance Discrimination Risks of Alzheimer's Disease Biomarkers. | J Law Med Ethics | 2018 | https://conductscience.org/library/papers/30147000 | PubMed |
| 19 | 28263740 | Safety of disclosing amyloid status in cognitively normal older adults. | Alzheimers Dement | 2017 | https://conductscience.org/library/papers/28263740 | PubMed |
| 20 | 27060950 | Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment. | J Alzheimers Dis | 2016 | https://conductscience.org/library/papers/27060950 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42507235 | Worry and Anxiety in the Era of Early Diagnosis and Disease Modifying Treatment for Alzheimer's Disease. | Curr Psychiatry Rep | 2026 | https://conductscience.org/library/papers/42507235 | PubMed |
| 41808917 | Multidisciplinary Formulation of a Walking Rehabilitation Nursing Protocol for Patients with Lower Extremity Arteriosclerosis Obliterans: A Delphi Study. | J Multidiscip Healthc | 2026 | https://conductscience.org/library/papers/41808917 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40997223
GET https://conductscience.org/api/papers/v1/40997223/authors?page=2